NEW YORK (Reuters Health) - Nearly one in ten U.S. children undergoing spine fusion surgery get injections with bioengineered bone-growth proteins that have not been approved for that use by health regulators, researchers have found. So-called "off-label" use of medical therapies is legal, but has triggered concerns because its risks and benefits are not well understood. What's more, the orthopedic products add more than $4,000 in hospital charges for the surgery, according to a new study published on Tuesday in Journal of the American Medical Association. For the full study, see: http://bit. ... via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment